HeartSciences Inc.
Market Cap
$5.95M
P/E Ratio
-0.39
EPS
$-6.79
Dividend Yield
0.00%
52-Week Range
$2.01 — $6.47
Volume
7.75K
Avg Volume
29.94K
Beta
2.54
P/E (TTM)
-0.39
Forward P/E
—
PEG Ratio
-0.05
P/S (TTM)
664.81
P/B (TTM)
1.71
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-3.88%
ROA (TTM)
-1.51%
ROIC
—
Gross Margin
-6.77%
Operating Margin
-950.44%
Net Margin
—
Debt/Equity
0.21
Current Ratio
2.42
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-14.09%
EPS Growth (5Y)
-8.54%
Sales Growth (3Y)
+0.40%
Sales Growth (5Y)
+0.03%
EPS Est (This Year)
$-3.82
EPS Est (Next Year)
$-3.44
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.70
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
2.24M
Float
2.03M
Free Float %
90.59%
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
NASDAQ
IPO Date
2022-06-16
Employees
15
CEO
Andrew Simpson
Index Membership
—
Website
https://heartsciences.com
HeartSciences Inc. (HSCS) is a healthcare company in the medical - devices industry listed on the NASDAQ. With a market capitalization of $5.95M, a P/E ratio of -0.39, HSCS is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare HSCS against other stocks using dozens of fundamental and technical filters.
HeartSciences Inc. (HSCS) has a trailing twelve-month (TTM) P/E ratio of -0.39. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, HeartSciences Inc. (HSCS) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
HeartSciences Inc. (HSCS) has a market capitalization of $5.95 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.